<DOC>
	<DOCNO>NCT00608712</DOCNO>
	<brief_summary>Phase IV , open-label , multicenter , non-randomized , 2 non-comparative investigational arm study , carry morbid obesity patient undergone gastric bypass surgery body weight reduction</brief_summary>
	<brief_title>Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs ( NSAIDS )</brief_title>
	<detailed_description />
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Written inform consent sign date BMI â‰¥40 kg/m2 BMI 35 40 kg/m2 , severe disease together obesity Indication gastric bypass surgery Upper digestive endoscopy prior surgery show esophagitis , erosion , ulcer neoplasia , examination perform 30 day surgery consider valid Helicobacter pylorus noninfected patient , diagnosed test carry 30 day surgery Contraindication gastric bypass surgery Contraindication use Omeprazole derivatives Patients carrier gastrinoma hypergastrinemia Patients contraindicate perform UDE Patients previous esophagogastroduodenal surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>bariatric surgery</keyword>
	<keyword>ulcer prevention</keyword>
</DOC>